maxikdiol

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namemaxikdiol
Drug Alias Name14-hydroxy CAF-603 oleateCAF-603 analog8-daucene-3,4-diol analog
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionPotassium channel agonists
TargetsPotassium channel
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A